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STUDIES ON ' 3:lXE WASH-OUT FROM HUMAN SKIN: QUANTITATIVE 
MEASUREMENTS OF BLOOD FLOW IN NORMAL AND CORTICOSTEROID-
TREATED SKIN 
JoHs. KJELDSTRUP KRISTENSEN, M.D .. AND SvEND WAosKov, M.D. 
Department of Dermatology. The University of Copenhagen. Rigshospital , Copenhagen, Denmark 
Blood flow was measured by the '3.1Xe technique in normal and corticosteroid-treated skin. 
Epicutaneous and intracutaneous methods of tracer application were compared in normal 
skin. The two labeling methods were equally suitable for measuring cutaneous blood flow 
provided calculations in both cases were based on a biexponential resolution of the wash-out 
curve in its cutaneous and subcutaneous components and provided the t raumatic hyperemia 
phase was considered, when intracutaneous application of the tracer was used. Results were 
invalidated if calculations were based on initial s lope of the wash-out curves. Topical 
application of beta-methasone valerate resulted in a reduction in cutaneous blood flow as 
measured by the intracutaneous technique with curve resolution. whereas no effect could be 
demonstrated when calculations were based on the initial slopes of the curves. 
The 133Xe technique is a simple and reliable method for measuring cutaneous blood flow, 
which might prove useful in estimations of penetration ability and potency of topical 
corticosteroids. 
Various methods for measuring cutaneous blood 
flow have been used in the past. but conflicting 
results reveal how the estimates of flow depend on 
the method applied 11]. The 133Xe wash-out method 
was elaborated by Sejrsen to provide optimal mea-
surement of the cutaneous blood flow in man [2.3]. 
The epicutaneous 13.1Xe wash-out method may be 
the only method hitherto used that can give quan-
titative values of blood flow in cutaneous tissue. 
Validation by comparison with other methods is 
not possible at the moment as plethysmography 
and heat clearance methods only estimate cuta-
neous blood flow in a semiquantitative or qualita-
tive fashion [ 1-3). However, few investigators 
have utilized the method, and then often with 
modifications that do not take the necessary pre-
cautions [4.5). 
The aim of this communication is to present 
results obtained by using the method as described 
by Sejrsen 13]. As an example of application of the 
method we have studied the effect of local cortico-
steroid treatment on cutaneous blood flow . 
MATERIALS AND METHODS 
Thirteen healthy volunteers were studied, 8 women 
and 5 men . aged 21 to 50. The volunteers were placed in 
the supine position, with the hands at heart level. None 
of the volunteers had sensations of heat or cold, nor 
were they sweating. The skin temperature, recorded at 
the beginning and at the end of each experiment, 
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ranged from 31•c to 35•c. The room temperature was 
22°C ± I SEM and the average humidity was 65 ± 4 
SEM. Both epicutaneous and intracutaneous tracer ap-
plication were used. 
Nine from the group re~:eived topi~:al appli~:atiun of 
0.1% bela-methasone valerate dissolved in a cream 
base of white Vaseline. paraffin oil. cetyl-stearyl alco-
hol. and carbowax. Control experiments with the cream 
base alone were carried out in the same subjects. The 
cream was applied 4 times at 6-hr intervals in a total 
amount of 100 mg to an area 4 em in diameter on the 
dorsum of a hand. Then, 2 hr after the last application. 
the blood flow was measured using the injection tech-
nique. 
Cutaneous blood flow was measured by the clearance 
of 133Xe according to the technique of Sejrsen [2,3J. 
Since '33Xe is an inert gas, no chemical binding of the 
tracer takes place in the tissue, and the gas is consid-
ered to be freely diffusible due to its considerable fat 
solubility [3]. Rapid and continuous diffusion equilib-
rium between the tissue perfused and the capillary 
blood is achieved [2,6]. No loss of '3aXe by routes other 
than the blood is evident (retrograde diffusion of gas 
through the skin has been shown to constitute approxi-
mately I % under nonsweating conditions [7] ), and a 
control for this is easily established by interrupting the 
blood flow to the limb by using a tourniquet (Fig. 1 ). 
Recirculation of the indicator may be neglected since a 
diffusion equilibrium is established in the lung [2). 
Application of Tracer 
Epicutaneous labeling. A gas mixture with a specific 
activity of20 mCi/ml was used (AB Atomenergi, Studs-
vik, Sweden 1. The 133Xe gas was deposited over the skin 
in a chamber formed by the sk.in and a Mylar mem-
brane. This membrane was 20 J.Lm in thickness, 6.5 em 
in diameter, and was mounted on a 1.5-cm wide adhe-
sive surface, surrounding the periphery of the mem· 
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brane. The adhesive surface was prepared from '' adhe-
sive discs" (Stomaseal, 3M Company, No. 1500). When 
the membrane was attached to the skin, 0.4- 0. 7 ml 
1:13Xe gas was injected by means of a gas-tight syringe 
and a thin needle into the chamber. The 133Xe gas 
remained in the chamber for 3 min to allow diffusion 
into the skin. The gas was drawn back into the syringe, 
the membrane was removed, and any excess gas re-
moved by blowing on the skin surface , before counting 
was started. 
I ntracutaneou.s labeling. Intracutaneous injections of 
"'Xe dissolved in sterile isotonic saline were adminis-
tered. The volume injected was from 0.01 to 0.04 mi. 
The injections were made by needles of 0.25-rom outer 
diameter. The specific activity of the injection fluid was 
3 to 20 mCi/ml. 
Counting Procedure 
After application of the tracer, the decline of radioac-
tivity at the application site was monitored externally, 
using a sodium iodide scintillation detector . The pulses 
from the detector were fed into a printing gamma-
spectrometer (Meditronic, Denmark). The center line 
was adjusted to the 0.081 Mev peak of gamma maxi-
mum energy of 13''Xe, the window being symmetrical 
around this peak. 
The counting rate was recorded at 1-min in tervals. 
Counting rates obtained by the epicutaneous method 
ranged from 2 x 1 0" to 10" and by t he intracutaneous 
method from 6 x 103 to 2 x 10'' counts per minute. After 
subtraction of background activity, the clearance 
curves were plotted on semilogarithmic paper . The 
counting was continued for at least 1 hr. 
Calculation of Cutaneous Blond Flott• 
The wash-out curves were analyzed graphically by 
the two-component model proposed by Sejrsen 12,3]. 
The wash-out curve of 1:13Xe is composed of the different 
clearance rates from the dermis and from the subcuta-
neous fat. As 1"Xe is highly soluble in lipid, the rate of 
removal from the subcutaneous fat is slow. The re-
corded curves can be resolved in the following manner: 
The monoexponential clearance of ' 33Xe from t he subcu-
taneous fat can be identified after 30 to 45 min when all 
measurable activity has been removed from t he dermis 
(component II, Fig. 2). This component is extrapolated 
to time zer o and subtracted from the total wash-out 
curve resulting in another monoexponential plot. which 
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FIG. 1. Application of the tourniquet stops the wash-
out. 
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FIG . 2. A wash-out curve obtained after epicutaneous 
tracer application in patient # l. The curve is analyzed 
according to the two-component model. Data points a re 
corrected for background activity. 
is the dermal clearance component (component I, Fig. 
2). The cutaneous blood t1 ow is calculated from the half 
time (T1d of the faster component (component I, Fig. 2) 
of the isotope wash-out curve, and from the tissue ro 
blood partition coefficient for '"~Xe, by the formula 
F = In 2 x A x 100 
T,2 
where F is the cutaneous blood flow expressed in ml/100 
gm · min , ln 2 is the natural logar ithm of 2. A is the 
tissue to blood partition coefficient in ml/gm, and T"2 is 
the half t ime of component L For cutaneous tissue. a A-
value of 0. 7 ml/gm is used 16]. 
ln addition to this resolution of the wash-out curves , 
data were also calculated from the initial slopes of the 
curves. A straight line was drawn through the initial 
linear part of t he curve, and T1,~ was calculated from 
this line . Only the first three data points could be fitted 
by the line. and the calculat ion was done only to com-
pare our results with those of other authors. 
RESULTS 
Comparison of the epicutaneous and intracuta-
neous technique. The results of the curve resolu-
tion based on 60-min monitoring periods are listed 
in Table I. showing agreement of results by the 
two techniques of tracer application . In Figure 3 
the actual curves of patient #I are shown , and 
from this the essential differences obtained bv the 
two-application techniques can be seen re~dily. 
The initial s lope is always steeper using the injec-
tion technique. but after 5 to IO min the curves 
assume the same course. Therefore, in this inves-
tigation when the injection technique was used, 
curve resolution was based on that part of the 
curves obtained after the first 10 min. Resolution 
of t he initial portion of the traumatic curve gave 
another bended curve until 5 to 10 min had 
elapsed. Thereafter , component I became monoex-
ponential as it was from the beginning of epicuta-
neous curves. After 30 to 45 min. the clearance 
curves with both labeling methods assumed the 
same slow monoexponential decrease. These tails 
of the curves were studied for an additional I5 min 
and could be fitted readily in all cases by a straight 
line (Fig. 3). In 10 experiments, the counting was 
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TABI.E I. Cutaneous blood flow 
Calculations with a resolution of the wash out-curves 
based on 60-min morutoring periods. T 1 ~is the halftime 
of component I. F is the cutaneous blood flow in ml!lOO 
gm · min. and z SEM · t99,. is the 99% confidence inter-
val, where SEM is the standard error of the mean. 
Intracutaneous 
Patient 
Epicutaneous 
T,, F T,,, F 
1 5.4 9.1 5.4 9.1 
2 7.0 7.0 6.0 8.1 
3 4.6 10.7 5.0 9.8 
4 4.6 10.7 4.8 10.2 
5 5.4 9.0 5.3 9.2 
6 5.2 9.4 5.0 9.8 
7 5.9 8.3 5.6 8.8 
8 5.5 8.9 5.6 8.8 
9 5.2 9.4 5.1 9.6 
10 5.0 9.8 4.9 10.0 
11 6.0 8.2 5.6 8.8 
12 5.9 8.3 7.0 7.0 
13 7.6 6.4 7.2 6.8 
Mean 8.9 8.9 
± SEM·t,...~ 1.2 0.9 
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FIG. 3. Wash-out curves from patient #1 , showing 
the essential difference in curves obtained by the two-
application techniques. After about 10 min, the intra-
cutaneous curve assumes the same course as the epicu-
taneous curve. 
continued for an additional 15 to 30 min. but no 
difference in the results could be detected. 
Analysis of curves obtained after epicutaneous 
tracer application. In Table II, the results of the 
epicutaneous technique are analyzed further. Re-
suits ofthe 60-min resolution are compared to flow 
calculations from the initial slope. It is evident 
Vol. 68 , N o. 4 
that. the initial slope calculations result in a con-
stant underestimation ofth e cutaneous blood flow. 
significantly different from the results based on 
the 60-rnin resolution. 
Analysis of curue8 obtained after intracutane-
ous trarcr application. From TablE.' III it can be 
seen that fl ow results based on the initial slope are 
high and show pronounced variations around the 
mean. To show the influence of the injection 
trauma, we calculated the peak traumatic flow in 
TABI.E IL Cutaneous blood flou• determined after 
epicutaneous tracer application 
F1~ = Flow calculation based on the initial slope of 
the curves. Flow results in ml/100 gm ·min. and = 
SEM · t9~% is the 99% confidence interval , where SEMis 
the standard error of the mean. 
Initial Resolution 
Patient slope 60 min FI~~ F,~, 
F" Frn, 
9.1 9.1 0.0 
2 5.8 8.1 -2.3 
3 7.9 9.8 - 1.9 
4 5.4 10.2 - 4.8 
5 5.7 9.2 - 3.5 
6 8.4 9.8 - 1.4 
7 6.] 8.8 - 2.7 
8 7.9 8.8 -0.9 
9 8.2 9.6 - 1.4 
10 8.9 10.0 - 1.1 
11 6.1 8.8 ') -... I 
12 4.9 7.0 -2.1 
13 5.3 6.8 -1.5 
Mean 6.9 8.9 -2.0 
:t SEM ·t,11~ 1.3 0.9 1.0 
TABLE ill. Cutaneou.~ blond f7nu · drtrrmmrd after 
intracutaneous tracrr application 
IS = Initial slope calculatiOns. C11 = Component II of 
the two-component resolution of the wash-out curve. 
Flow results in ml!100 gm·min. and =: SEM·t,,.,q is the 
99~ confidence intervaL 
A B C D 
Patient IS Resolu· Traumatic 
IS minus tion 60 flow 
c,, min CB-Cl 
1 24.5 27.2 9.1 18.1 
2 14.3 18.8 7.0 11.8 
3 30.6 35.0 10.7 24.3 
4 12.3 14 .8 10.7 4.1 
5 12.3 17.5 9.0 8.5 
6 27.2 28.8 9.4 19.4 
7 25.8 28.8 8.3 20.5 
8 25.8 30.6 8.9 21.7 
9 17.5 21.3 9.4 11.9 
10 9.4 17 .5 9.8 7.7 
11 19.6 22.3 8.2 14 .1 
12 14.8 22.3 8.3 14.0 
13 6.1 8.2 6.4 1.8 
Mean 18.5 22.6 8.9 13.7 
:t SEM-~"~ 6.4 6.1 1.2 5.8 
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the following manner: Component II was sub-
tracted from the initial slope and blood flow was 
calculated from the new slope by the method de-
scribed for initial slope calculations (B , Tab. III). 
Flow results based on a 60-min resolution have 
been subtracted from B to give the traumatic flow 
rate CD , Tab. III). In Figure 3, a representative 
curve is shown and the method of curve resolution 
illustrated . 
Demonstration of the local effect of .steroid treat-
ment. The results are presented in Table IV. show-
ing a significant reduction in cutaneous blood flow 
after treatment with topical corticosteroid (beta-
methasone valerate in a cream base). A monitor-
ing time of 60 min has been used. Calculations 
TABLE IV. Effect of beta-methasone ualerate on 
cutaneous blood {lou· 
NO = Not done. SEM = standard error of the mean. 
Using the paired Student's 1-test, a significant reduc-
tion in blood flow from control values is demonstrated . 
Flow results in ml/lOO gm·min. and ::t SEM·t.,.,'k is the 
99%· confidence interval. 
Patient 
2 
3 
4 
5 
6 
10 
11 
13 
16 
Mean 
A B C 
Normal 
skin 
9.1 
7.0 
10.7 
10.7 
9.0 
9.4 
9.8 
8.2 
6.4 
9.4 
9.0 
Cream 
base 
8.5 
NO 
10.9 
9.8 
8.4 
9.1 
9.4 
8.3 
7.7 
9.7 
9.1 
Cream 
with 
steroid 
7.7 
6.6 
9.8 
7.7 
6.6 
8.1 
7.9 
6.0 
5.9 
ND 
7.4 
= SEM ·t,.,,<l 1.5 1.1 1.3 
Student's /-test of paired variables \B & Cl p < 0.001 
TABLE V Cutaneous blo11d f7rm uswg the initial slop!' 
(!'('hlltQl/1' 
F , = Control values. F~ = flow results after applica-
tion of beta-methasone valerate in cream base. Flow 
results in ml/100 - GM·min. and ::t SEM·t.,.,,. is the 99%-
confidence interval. 
Patient F , F, 
1 24.5 12.9 
2 14.8 13.6 
3 30.6 32.7 
4 12.3 16.3 
5 12.3 37.7 
6 27.7 35.0 
10 9.4 11.1 
11 19.6 20.4 
13 6.1 16.3 
Mean 17.5 21.8 
:t SEM·t.,,,.~ 9.6 12.3 
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based on the initial slope technique fail to show 
any reduction in flow (Tab. V). 
DISCUSSION 
The results of our investigation are in agree-
ment with those of other authors [2,7] and indicate 
that the ':J:1Xe technique is a simple and accurate 
method for measuring cutaneous blood flow , pro-
vided the calculations are based on correct inter-
pretation of the wash-out curves. Correct interpre-
tation implies a biexponential resolution of the 
curves of one exponent representing the derma] 
tissue, and the other the subcutaneous tissue. This 
is essential since t:L3Xe, due to its high lipid solubil-
ity. is accumulated in the subcutaneous adip?se 
tissue from the very beginning of tracer labeling 
irrespective of the method of application. This is 
evident from our results using the epicutaneous 
method (Tab. II). where calculations based on the 
initial slope of the curves give an underestimation 
of the blood fl ow compared to the results obtained 
after subtraction of the subcutaneous component. 
Because of this underestimation. calculations 
based on the initial slope of epicutaneous curves 
cannot be used for quantitative measurements. 
This method of calculation could prove useful. 
however. in comparative investigations as used by 
Greeson and co-workers 18]. 
In the study of Sejrsen 12.3] great emphasis was 
laid on justifying the employment of compartmen-
tal analysis by showing that the components o~­
tained correspond to existing anatomic and physi-
ologic compartments. The mathematical model :x-
pressing two monoexponential components acting 
in series and in parallel has been worked out [2]. 
When intracutaneous applications are used. cor-
rect interpretation implies that the first part of the 
curve. representing the injection phase. is dis-
carded as the injection itself produces a temporary 
local hyperemia at the site of application 12]. This 
phase has to be terminated before biexponential 
resolution of the curves can be applied. 
A hyperemic reaction to intracutaneous injec-
tion of 1:13Xe was demonstrated by Sejrsen 13] in 
simultaneous experiments in which 0.003 ml of 
'
3:'Xe in saline was injected intracutaneously into 
the lateral aspect of one crus by means of a needle 
of 0.25-mm extemal diameter, using a microinjec-
tion syt;nge, the injection being made over a pe-
riod of 3 min. while during the same period '3.1Xe 
gas was applied epicutaneously on the correspond-
ing site of the other leg. The wash-out curves 
measured over the injection depots showed a stee-
per initial fall than the curves recorded over the 
depots applied epicutaneously [3]. Experimental 
support for the evaluation of the effect of injection 
was alsp provided by experiments with intr~cuta­
neous injection of t:~1Xe in saline into the skin fold 
between the thumb and the index finger. covering 
the remainder of the hand with a lead plate to 
obtain an isolated skin preparation. Here. the 
blood flow through the skin was calculated to be 2 
to 2.5 times greater than the flow obtained using 
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a traumatic epicutaneous labeling of the same skin 
site r3J. Another relevant observation was that a 
shortening of the epicutaneous application time to 
0.5 min did not change the shape of the initial part 
of the epicutaneous curve r3J. Sejrsen's conclusion 
of these experiments was that injection, in most 
cases, produced a temporary local hyperemia. 
Here again our results are in full agreement with 
those of Sejrsen r2,3]. From our analysis of the 
intracutaneous curves it is evident that attempts 
to use the initial slopes of intracutaneous curves 
for calculations of blood flow will give invalid re-
sults as individual responses to the injection 
trauma show pronounced variations. The initial 
parts of traumatic curves have at least three expo-
nents. composed of traumatic. cutaneous, and sub-
cutaneous components. Therefore, this initial part 
cannot be used for quantitative measurements of 
cutaneous blood flow. Our results, obtained on the 
dorsum of the hand, compared to those of Sejrsen. 
obtained on the lateral aspect of the leg , indicate 
that the duration of the injection phase varies 
within different skin regions r2). Sejrsen found an 
injection phase ofl5 min and a blood flow of6.1 ml/ 
100 gm/min, which, compared with our results, 
could indicate that regions with a relatively high 
flow have a shorter injection phase . Thus. when 
the intracutaneous technique is applied to new 
areas. one has to determine the length of this 
phase to make calculations valid. It has been 
shown, then. on empirical grounds. that the intra-
cutaneous method can be used . provided the neces-
sary precautions are taken 12.3,9]. The agreement 
in our results. obtained by the epicutaneous and 
the int racutaneous technique, generally renders 
both methods equally suitable. However , consider-
ations of potential errors may favor one of the 
techniques in a given situation. In our study of 
steroid-induced hypoemia. the intracutaneous 
method was chosen to avoid the possibility of error 
which might have occurred if the epicutaneous 
method had been applied . and, due to its lipid 
solubility. 133Xe was retained in the vehicle. The 
monitoring time necessary for the resolution of the 
curves in their two components depends on an 
adequate definition of the monoexponential subcu-
taneous component. On the dorsum of the hand a 
period of60 min is adequate to obtain valid r esul ts 
(Fig . 1). 
Furthermore, our results show that the 1a.1Xe 
technique can be a method for measurement ofthe 
effect of topically appl ied corticosteroids on cuta-
neous vasculature. Application of beta-methasone 
valerate resul ted in a reduction of cutaneous blood 
flow, when the curves were analyzed according to 
the two-component model. Using the initial slope 
of the curves as the basis of calculations as used by 
Chimoskey and co-workers 14], no effect of the 
corticosteroid could be demonstrated (Tab. V). 
Thus, we have been unable to confrrm their re-
sults. which were based on a traumatic initial 
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slope method. Also, observations on blood flow in 
psoriatic plaques need confirmation due to the use 
of the initial slope method rsJ. 
The 133Xe method may prove useful in evalua-
tion of new corticosteroids for topical use and in 
assessing their role in the therapy of cutaneous 
disorders. McKenzie and Stoughton 110,11] were 
able to correlate cutaneous pallor with clinical 
potency of topically applied corticosteroids and ar-
gued that this vasoconstriction assay could be a 
screening technique for anti-inflammatory action 
despite the inherent low precision of the method. 
Stoughton 112] even found the assay system useful 
in predicting the effectiveness of a given vehicle in 
enhancing percutaneous absorption of corticoste-
r oids. This finding has been confirmed by other 
workers ri3]. However , the steroid-induced pallor 
is judged by eye and probably is related to more 
than just vasoconstriction r 1 4]. Therefore, it seems 
likely that the 133Xe method may prove to be a 
more objective method in assessing the effect of 
topically applied corticosteroids on cutaneous vas-
culature. 
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